Page 6 - Kineta Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kineta (KA) Provides Update on its Ongoing Phase 1/2 VISTA-101 Trial of KVA12123

Kineta (KA) Provides Update on its Ongoing Phase 1/2 VISTA-101 Trial of KVA12123
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThierry guillaudeuxShawn iadonatoKineta incMerck co incMerck sharp dohmeChief executive officerReceptor occupancyChief scientific officerMerck sharp

Kineta Issues Update On Phase 1/2 VISTA-101 Trial Of KVA12123 - Quick Facts

(RTTNews) - Kineta, Inc. (KA) issued an update on ongoing VISTA-101 Phase 1/2 clinical trial evaluating KVA12123 in patients with advanced solid t.

Shawn iadonatoKineta incMore such health news

Kineta, Inc (NASDAQ:KA) Sees Significant Drop in Short Interest

Kineta, Inc. (NASDAQ:KA – Get Free Report) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 44,700 shares, a decline of 13.4% from the November 30th total of 51,600 shares. Approximately 0.6% of the shares of the stock are short […]

Kineta incAsset management incColony groupBlackrock incGeode capital managementRenaissance technologiesGet free reportManagement incCapital managementKineta dailyNasdaq ka

Life Science Investor Forum: Presentations Now Available For Online Viewing

Life Science Investor Forum: Presentations Now Available For Online Viewing
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Johnm viglottiNeurobo pharmaceuticals incLife science investor forumNasdaq company executives share visionGroup incLife sciences incElse nutrition holdings incBioharvest sciences incReviva pharmaceuticals holdings incKineta incCap researchCorporate servicesCompany executives share visionAnswer questions liveInvestor conferencesZacks small cap

Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer

Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thierry guillaudeuxShawn iadonatoJohn mullalylifesci advisorsJacques bouchyevp investor relations business developmentKineta incTherapy against poorly immunogenicHighly potentNew immune checkpoint inhibitorPromising therapy against poorly immunogenicChief scientific officerChief executive officerStatements regarding forward lookingPrivate securities litigation reform actAnnual reportQuarterly reports